Brazil news from FiercePharma
News
Brazil poised for big pharma growth
Guess who's the new up-and-comer in pharma? Brazil. Despite a burdensome tax structure, foreign companies are investing heavily in the country, taking advantage of incentives to entry into its... Read more...
Brazil mulls patent-busting on Tenofovir
The Brazilian government recently deemed the anti-HIV med Tenofovir a "public interest." That's code for, "We're thinking about issuing a compulsory license for this drug." Under... Read more...
Get more Brazil coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
